Published on 19 Apr 2023 on Simply Wall St. via Yahoo Finance
Cautious Investors Not Rewarding SNDL Inc.'s (NASDAQ:SNDL) Performance Completely
You may think that with a price-to-sales (or "P/S") ratio of 1.1x SNDL Inc. (NASDAQ:SNDL) is a stock worth checking out, seeing as almost half of all the Pharmaceuticals companies in the United States have P/S ratios greater than 3.1x and even P/S higher than 16x aren't out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.
See our latest analysis for SNDL
